If you are in middle aged and find you have to hold your phone at arm’s length to read, you may have presbyopia – a difficulty focusing on close objects that is usually corrected using glasses, contact lenses or laser eye surgery.
Now, there could be another alternative, in the form of eye drops administered daily, according to AbbVie’s Allergan subsidiary, which reported new phase 3 data for its pilocarpine formulation – codenamed AGN-190584 – at the American Society of Cataract and Refractive Surgery (ASCRS) congress over the weekend.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,